BusinessBioStem Technologies Inc. Enters Into Consulting and Advisory Agreement with Dr. Irmgard HuberBy Nasdaq OMXApr 4, 2018, 2:28 PM UTC
BusinessBioStem Technologies Inc. Announces a Pre-Clinical Study of BSEM17-115 at University of MiamiBy Nasdaq OMXDec 11, 2017, 2:43 PM UTC